Our API manufacturing facilities are operated in accordance with cGMP (ICH Q7) and are regularly inspected/audited by international regulatory authorities and numerous customers. We have eight commercial USFDA inspected production units, from which six production units are in India, and one in Mexico and the UK.
- 6 manufacturing units
- Manufacturing capabilities include HPAPI, oncology, and other synthetic molecules
- Located in Cuernavaca
- Steroid manufacturing capabilities
- Located in Mirfield
- Manufacturing capabilities include Prostaglandins and PEGylation
Our API manufacturing plants are complemented by formulation manufacturing facilities which can supply a variety of different dosage forms.